Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

MATTHEW A POWELL

Allopathic & Osteopathic Physicians Obstetrics & Gynecology Gynecologic Oncology

NPI
1609894187
CMS profile
345918
Location
SAINT LOUIS, MO

General Payments · PY2018–2024

$263,315.86

  • Reported across 323 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$12,767.99

28 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Consulting Fee $11,755.00 5
Food and Beverage $1,012.99 23

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
GlaxoSmithKline, LLC. $8,093.38 9
BioNTech SE $2,200.00 1
ImmunoGen, Inc. $1,479.00 2
Acerta Pharma LLC $647.49 5
Arthrex, Inc. $143.33 2
Genmab U.S., Inc. $59.57 2
Merck Sharp & Dohme Corporation $44.71 2
ABBVIE INC. $37.89 2
EISAI INC. $34.84 2
Karyopharm Therapeutics Inc. $27.78 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $111,060.60 125
PY2019 $62,544.44 89
PY2020 $24,625.92 19
PY2021 $27,645.80 17
PY2022 $12,048.95 20
PY2023 $12,622.16 25
PY2024 $12,767.99 28

Payment records · PY2024 (28)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $17.23 02/13/2024 Food and Beverage Undisputed 01/23/2026 1105304276 CMS
ABBVIE INC. $20.66 11/05/2024 Food and Beverage Undisputed 01/23/2026 1105304280 CMS
Arthrex, Inc. $103.33 12/05/2024 Food and Beverage Undisputed 01/23/2026 1146570551 CMS
Arthrex, Inc. $40.00 12/31/2024 Food and Beverage Undisputed 01/23/2026 1146570553 CMS
AstraZeneca Pharmaceuticals LP $42.07 01/24/2024 Food and Beverage Undisputed 01/23/2026 1104531722 CMS
AstraZeneca Pharmaceuticals LP $555.00 03/03/2024 Consulting Fee Undisputed 01/23/2026 1105259716 CMS
AstraZeneca Pharmaceuticals LP $13.63 11/01/2024 Food and Beverage Undisputed 01/23/2026 1104380867 CMS
AstraZeneca Pharmaceuticals LP $14.28 11/01/2024 Food and Beverage Undisputed 01/23/2026 1105576018 CMS
AstraZeneca Pharmaceuticals LP $22.51 11/08/2024 Food and Beverage Undisputed 01/23/2026 1104376005 CMS
BioNTech SE $2,200.00 01/12/2024 Consulting Fee Undisputed 01/23/2026 1150660518 CMS
Eisai Inc. $17.11 02/20/2024 Food and Beverage Undisputed 01/23/2026 1110764627 CMS
Eisai Inc. $17.73 04/24/2024 Food and Beverage Undisputed 01/23/2026 1110764625 CMS
Genmab U.S., Inc. $31.14 03/12/2024 Food and Beverage Undisputed 01/23/2026 1126829566 CMS
Genmab U.S., Inc. $28.43 07/31/2024 Food and Beverage Undisputed 01/23/2026 1126829568 CMS
GlaxoSmithKline, LLC. $84.45 01/24/2024 Food and Beverage Undisputed 01/23/2026 1116547669 CMS
GlaxoSmithKline, LLC. $123.60 01/24/2024 Food and Beverage Undisputed 01/23/2026 1116604490 CMS
GlaxoSmithKline, LLC. $28.00 01/24/2024 Food and Beverage Undisputed 01/23/2026 1116699793 CMS
GlaxoSmithKline, LLC. $5,200.00 02/22/2024 Consulting Fee Undisputed 01/23/2026 1116470360 CMS
GlaxoSmithKline, LLC. $20.73 03/15/2024 Food and Beverage Undisputed 01/23/2026 1116374100 CMS
GlaxoSmithKline, LLC. $71.66 03/15/2024 Food and Beverage Undisputed 01/23/2026 1116722447 CMS
GlaxoSmithKline, LLC. $42.66 03/17/2024 Food and Beverage Undisputed 01/23/2026 1116242886 CMS
GlaxoSmithKline, LLC. $2,400.00 05/10/2024 Consulting Fee Undisputed 01/23/2026 1116533326 CMS
GlaxoSmithKline, LLC. $122.28 12/04/2024 Food and Beverage Undisputed 01/23/2026 1116267934 CMS
ImmunoGen, Inc. $79.00 01/26/2024 Food and Beverage Undisputed 01/23/2026 1099941759 CMS
ImmunoGen, Inc. $1,400.00 01/26/2024 Consulting Fee Undisputed 01/23/2026 1099941761 CMS
Karyopharm Therapeutics Inc. $27.78 09/27/2024 Food and Beverage Undisputed 01/23/2026 1145533448 CMS
Merck Sharp & Dohme LLC $26.19 03/05/2024 Food and Beverage Undisputed 01/23/2026 1141628045 CMS
Merck Sharp & Dohme LLC $18.52 07/10/2024 Food and Beverage Undisputed 01/23/2026 1141845755 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.